Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study
Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study
NCT ID: NCT00469326 Phase: PHASE3 Status: COMPLETED Enrollment: 200 Completion: 2008-12
Conditions
Coronary Artery Disease
Interventions
Atorvastatin
Summary
This study investigates potential protective effect of atorvastatin pre-treatment in patient with stable coronary artery disease undergoing percutaneous coronary intervention (PCI). Patient are randomized to two groups: atorvastatin pre-treatment group (80mg atorvastatin two days before PCI) and control group (PCI without atorvastatin pretreatment). Endpoint is myocardial infarction measured by troponin I and creatine kinase myocardial band.
Primary Outcome
periprocedural myocardial infarction measured by troponin I level